SeaStar Medical Holding Corp ICU.OQ reported a quarterly adjusted loss of $1.10 per share for the quarter , higher than the same quarter last year, when the company reported EPS of $-9.00. The lone analyst forecast for the quarter was for a loss of $1.13 per share.
Revenue was $136.00 thousand; analysts expected $75.00 thousand.
SeaStar Medical Holding Corp's reported EPS for the quarter was a loss of $1.10.
The company reported a quarterly loss of $4.48 million.
SeaStar Medical Holding Corp shares had fallen by 37.3% this quarter and lost 75.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 9.6% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $18.00
This summary was machine generated from LSEG data November 14 at 03:53 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -1.13 | -1.10 | Beat |
Jun. 30 2024 | -1.41 | -1.03 | Beat |
Mar. 31 2024 | -3.75 | -4.75 | Missed |
Dec. 31 2023 | -3.25 | -5.50 | Missed |
Comments